WO1997025917A1 - Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels - Google Patents

Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels Download PDF

Info

Publication number
WO1997025917A1
WO1997025917A1 PCT/US1997/000896 US9700896W WO9725917A1 WO 1997025917 A1 WO1997025917 A1 WO 1997025917A1 US 9700896 W US9700896 W US 9700896W WO 9725917 A1 WO9725917 A1 WO 9725917A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrically
network
electrode segments
exterior wall
controller
Prior art date
Application number
PCT/US1997/000896
Other languages
English (en)
Other versions
WO1997025917A9 (fr
Inventor
Dorin Panescu
David K. Swanson
James G. Whayne
Jerome Jackson
Original Assignee
Ep Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/629,014 external-priority patent/US5836874A/en
Application filed by Ep Technologies, Inc. filed Critical Ep Technologies, Inc.
Priority to JP9526268A priority Critical patent/JP2000504242A/ja
Priority to EP97903022A priority patent/EP0879015A4/fr
Publication of WO1997025917A1 publication Critical patent/WO1997025917A1/fr
Publication of WO1997025917A9 publication Critical patent/WO1997025917A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/06—Electrodes for high-frequency therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00059—Material properties
    • A61B2018/00065—Material properties porous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00059—Material properties
    • A61B2018/00071—Electrical conductivity
    • A61B2018/00083—Electrical conductivity low, i.e. electrically insulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00059—Material properties
    • A61B2018/00089—Thermal conductivity
    • A61B2018/00095—Thermal conductivity high, i.e. heat conducting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00107—Coatings on the energy applicator
    • A61B2018/00113—Coatings on the energy applicator with foam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00107—Coatings on the energy applicator
    • A61B2018/00148—Coatings on the energy applicator with metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022—Balloons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636—Sensing and controlling the application of energy
    • A61B2018/00773—Sensed parameters
    • A61B2018/00839—Bioelectrical parameters, e.g. ECG, EEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B2018/1246—Generators therefor characterised by the output polarity
    • A61B2018/1253—Generators therefor characterised by the output polarity monopolar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002—Irrigation

Definitions

  • the invention generally relates to electrode structures deployed in interior regions of the body. In a more specific sense, the invention relates to electrode structures deployable into the heart for diagnosis and treatment of cardiac conditions.
  • Physicians examine the propagation of electrical impulses in heart tissue to locate aberrant conductive pathways.
  • the aberrant conductive pathways constitute peculiar and life threatening patterns, called dysrhythmias.
  • the techniques used to analyze these pathways commonly called “mapping, " identify regions in the heart tissue, called foci, which are ablated to treat the dysrhythmia.
  • Conventional cardiac tissue mapping techniques use multiple electrodes positioned in contact with epicardial heart tissue to obtain multiple electrograms.
  • Digital signal processing algorithms convert the electrogram morphologies into isochronal displays, which depict the propagation of electrical impulses in heart tissue over time.
  • These conventional mapping techniques require invasive open heart surgical techniques to position the electrodes on the epicardial surface of the heart.
  • ischemic tissue occupying the border zone between infarcted tissue and healthy tissue has an electrical resistivity that is about two-thirds that of healthy heart tissue. See, e.g., Fallert et al., "Myocardial Electrical Impedance Mapping of Ischemic Sheep Hearts and Healing Aneurysms," Circulation, Vol. 87, No. 1, January 1993, 199-207.
  • Panescu U.S. Patent 5,487,391 and Panescu et al U.S. Patent 5,485,849 demonstrate that this observed physiological phenomenon, when coupled with effective, non-intrusive measurement techniques, can lead to cardiac mapping systems and procedures with a CIR better than conventional mapping technologies.
  • the Panescu '391 and '849 Patents use a multiple electrode structure and signal processing methodologies to examine heart tissue morphology quickly, accurately, and in a relatively non-invasive manner.
  • the systems and methods disclosed in the Panescu '391 and , 849 Patents transmit electrical current through a region of heart tissue lying between selected pairs of the electrodes, at least one of the electrodes in each pair being located within the heart. Based upon these current transmissions, the systems and methods derive the electrical characteristic of tissue lying between the electrode pairs. This electrical characteristic (called the "E-Characteristic") can be directly correlated to tissue morphology.
  • E-Characteristic an electrical characteristic of tissue lying between the electrode pairs.
  • E-Characteristic indicates infarcted heart tissue, while a high relative E-Characteristic indicates healthy heart tissue.
  • Intermediate E-Characteristic values indicate the border of ischemic tissue between infarcted and healthy tissue.
  • the treatment of cardiac arrhythmias also requires electrodes capable of creating tissue lesions having a diversity of different geometries and characteristics, depending upon the particular physiology of the arrhythmia to be treated.
  • a conventional 8F diameter/4mm long cardiac ablation electrode can transmit radio frequency energy to create lesions in myocardial tissue with a depth of about 0.5 cm and a width of about 10 mm, with a lesion volume of up to 0.2 cm 3 .
  • These small and shallow lesions are desired in the sinus node for sinus node modifications, or along the A-V groove for various accessory pathway ablations, or along the slow zone of the tricuspid isthmus for atrial flutter (AFL) or AV node slow pathways ablations.
  • VT ventricular tachycardia
  • Multi-purpose cardiac ablation electrodes that can both examine the propagation of electrical impulses in heart tissue and also create lesions of different geometries and characteristics.
  • Multi-purpose electrodes would possess the requisite flexibility and maneuverability permitting safe and easy introduction into the heart. Once deployed inside the heart, these electrodes would possess the capability to map cardiac tissue and to emit energy sufficient to create, in a controlled fashion, either large and deep lesions, or small and shallow lesions, or large and shallow lesions, depending upon the therapy required. 3unn ⁇ m ⁇ » ⁇ of the Invention
  • One aspect of the invention provides multi-function systems and methods for use in association with body tissue.
  • the systems and methods employ a structure including an exterior wall adapted to contact tissue, which carries an array of electrically conducting electrode segments.
  • An electrically conductive network is coupled to the electrode segments, including at least one electrically conductive path individually coupled to each electrode segment.
  • a controller is coupled to the electrically conductive network. The controller operates in a first mode during which the network is electrically conditioned to individually sense at each electrode segment local electrical events in tissue, such as electrical potentials, resistivity, or impedance.
  • the controller further operates in a second mode during which the network is electrically conditioned, based at least in part upon local electrical events sensed by the electrode segments, to couple at least two electrode segments together to simultaneously transmit electrical energy to create a physiological effect upon a region of body tissue, such as heating or ablating the tissue region.
  • the controller operates in conjunction with the array of electrode segments in a first mode during which the network is electrically conditioned to individually transmit through each electrode segment electrical energy creating a local physiological effect upon body tissue, such as electrically stimulating localized tissue.
  • the controller further operates in a second mode during which the network is electrically conditioned to couple at least two electrode segments together to simultaneously transmit electrical energy creating a regional physiological effect upon body tissue, such as heating or ablating the tissue region.
  • Another aspect of the invention provides systems and methods for pacing heart tissue.
  • the systems and methods make use of a structure including an exterior wall adapted to contact heart tissue.
  • the exterior wall is adapted to selectively assume an expanded geometry having a first maximum diameter and a collapsed geometry having a second maximum diameter less than the first maximum diameter.
  • the exterior wall carries electrically conducting electrodes.
  • An electrically conductive network is coupled to the electrodes, including at least one electrically conductive path individually coupled to each electrode.
  • a controller is coupled to the electrically conductive network.
  • the controller operates in a first mode during which the network is electrically conditioned to transmit electrical energy through the electrodes to pace heart tissue.
  • the controller further operates in a second mode during which the network is electrically conditioned to sense electrical events through the electrodes.
  • FIG. 1 is a view of a system for analyzing the morphology of heart tissue that embodies the features of the invention
  • Fig. 2 is an enlarged side view of an expandable-collapsible electrode structure associated with the system shown in Fig. 1, shown in the expanded geometry;
  • Fig. 3 is an enlarged side view of the expandable-collapsible electrode structure shown in Fig. 2, shown in the collapsed geometry;
  • Fig. 4 is an enlarged and somewhat diagrammatic view of the surface of the electrode structure shown in Figs. 2 and 3, showing the high density pattern of electrode segments;
  • Fig. 5 is a side elevation view of an expandable-collapsible electrode structure associated with the system shown in Fig. 1, with an interior spline support structure shown in its expanded geometry;
  • Fig. 6 is a side elevation view of the expandable-collapsible electrode structure shown in Fig. 5, with its interior spline support structure shown in its collapsed geometry;
  • Fig. 7 is a side elevation view of an expandable-collapsible electrode structure associated with the system shown in Fig. 1, with an interior mesh support structure shown in its expanded geometry;
  • Fig. 8 is a side elevation view of an expandable-collapsible electrode structure associated with the system shown in Fig. l, the structure having an electrically conductive body;
  • Fig. 9 is a side elevation view of an expandable-collapsible electrode structure with a bull's eye pattern of electrode zones;
  • Fig. 10 an expandable-collapsible electrode structure with a circumferentially spaced pattern of electrode zones;
  • Fig. 11 is an expandable-collapsible electrode structure suitable for noncontact mapping of the interior of the heart.
  • Fig. 1 shows the components of a system
  • the system 10 includes a flexible catheter tube 12 with a proximal end 14 and a distal end 16.
  • the proximal end 14 carries a handle 18.
  • the distal end 16 carries an electrode structure 20, which embodies features of the invention.
  • the physician uses the electrode structure 20 in association with a process controller 40 to take multiple, sequential measurements of the transmission of electrical current through heart tissue. Based upon these current transmissions, the controller 40 derives the electrical characteristic of tissue lying between the electrode pairs, called the
  • E-Characteristic The E-Characteristic can be directly correlated to tissue morphology.
  • the electrode structure 20 can be also used to ablate tissue in the system 10.
  • the electrode structure 20 includes an expandable-collapsible body 22.
  • the geometry of the body 22 can be altered between a collapsed geometry (Fig. 3) and an enlarged, or expanded, geometry (Fig. 2) .
  • fluid pressure is used to inflate and maintain the expandable-collapsible body 22 in the expanded geometry.
  • the catheter tube 12 carries an interior lumen 34 along its length.
  • the distal end of the lumen 34 opens into the hollow interior of the expandable- collapsible body 22.
  • the proximal end of the lumen 34 communicates with a port 36 (see Fig. 1) on the handle 18.
  • the expandable- collapsible body 22 can be urged into a significantly expanded geometry of, for example, approximately 7 to 20 ram.
  • the structure 20 can include, if desired, a normally open, yet collapsible, interior support structure 43 to apply internal force to augment or replace the force of fluid medium pressure to maintain the body 22 in the expanded geometry.
  • the form of the interior support structure 43 can vary. It can, for example, comprise an assemblage of flexible spline elements 25, as shown in Fig. 5, or an interior porous, interwoven mesh or open cell foam structure 26, as shown in Fig. 7.
  • the internally supported expandable-collapsible body 22 is brought to a collapsed geometry, after the removal of the inflation medium, by outside compression applied by an outer sheath 28 (see Fig. 6), which slides along the catheter tube 12.
  • an outer sheath 28 see Fig. 6
  • forward movement of the sheath 28 advances it over the expanded expandable- collapsible body 22.
  • the expandable-collapsible body 22 collapses into its low profile geometry within the sheath 28.
  • Rearward movement of the sheath 28 retracts it away from the expandable-collapsible body 22.
  • the expandable-collapsible body 22 can be formed about the exterior of a glass mold. In this arrangement, the external dimensions of the mold match the desired expanded geometry of the expandable-collapsible body 22.
  • the mold is dipped in a desired sequence into a solution of the body material until the desired wall thickness is achieved. The mold is then etched away, leaving the formed expandable-collapsible body 22.
  • the expandable-collapsible body 22 may also be blow molded from extruded tube.
  • the body 22 is sealed at one end using adhesive or thermal fusion.
  • the opposite open end of the body 22 is left open.
  • the sealed expandable-collapsible body 22 is placed inside the mold.
  • An inflation medium, such as high pressure gas or liquid, is introduced through the open tube end.
  • the mold is exposed to heat as the tube body 22 is inflated to assume the mold geometry.
  • the formed expandable-collapsible body 22 is then pulled from the mold.
  • Various specific geometries can be selected.
  • the preferred geometry is essentially spherical and symmetric, with a distal spherical contour, as Fig. 2 shows.
  • the body 22 when used in the ventricle, the body 22 should have a generally spherical contour. When used in the atrium, the body 22 should have a generally elongated contour. When used epicardially, the body 22 should have a generally concave contour.
  • the structure 20 includes an array of small electrode segments 44 overlying all or a portion of the expandable-collapsible body 22. The array orients the small electrode segments 44 in a high density, closely spaced relationship. The resistivity of each electrode segment 44 is low relative to the resistivity of the body 22 spacing the segments 44 apart.
  • the electrode segments 44 comprise metal, such as gold, platinum, platinum/iridium, among others, deposited upon the expandable-collapsible body 22 by sputtering, vapor deposition, ion beam deposition, electroplating over a deposited seed layer, photo-etching, multi-layer processes, or a combination of these processes.
  • the signal paths 32 are deposited on the body using conventional photo- etching or multi-layer processes.
  • the signal paths 32 communicate with wires 33, which extend through catheter tube 12 for coupling to connectors 38 carried by the handle 18.
  • a distal steering mechanism 52 (see Fig. 1) enhances the manipulation of the electrode structure 20 both during and after deployment.
  • the steering mechanism 52 can vary.
  • the steering mechanism 52 includes a rotating cam wheel 56 coupled to an external steering lever 58 carried by the handle 18.
  • the cam wheel 56 holds the proximal ends of right and left steering wires 60.
  • the wires 60 pass with the signal wires 33 through the catheter tube 12 and connect to the left and right sides of a resilient bendable wire or leaf spring (not shown) adjacent the distal tube end 16. Further details of this and other types of steering mechanisms are shown in Lundquist and Thompson U.S. Patent 5,254,088, which is incorporated into this Specification by reference.
  • the array of electrode segments 44 functions in both a diagnostic mode and a therapeutic mode.
  • each segment 44 is conditioned by the controller 40 to transmit electrical current through tissue.
  • the electrode segments 44 can transmit electrical current in either a unipolar mode or a bipolar mode. When operated in a unipolar mode, the current return path is provided by an exterior indifferent electrode attached to the patient. When operated in a bipolar mode, the current return path is provided by an electrode segment located immediately next to or spaced away from the selected transmitting electrode segment 44.
  • the controller 40 acquires impedance information about the heart tissue region that the electrode segments 44 contact.
  • the impedance information is processed by the controller 40 to derive the E-Characteristic, which assists the physician in identifying regions of infarcted tissue where ablation therapy may be appropriate.
  • the coupled electrode segments 44 being held by the body in intimate contact with tissue and thereby shielded from contact with the blood pool, direct essentially all current flow into tissue, thereby obtaining tissue characteristic information free of artifacts.
  • the high density of electrode segments 44 carried by the expandable-collapsible body 22 also provides superior signal resolution for more accurate identification of the potential ablation region.
  • the controller 40 electrically couples a grid of adjacent electrode segments 44 together overlying the identified region to a source 42 of ablation energy.
  • the coupled electrode segments simultaneously receive ablation energy from the source 42 (see Fig. 1) , thereby serving as a large-surface area transmitter of the energy.
  • the type of ablation energy used can vary, in the illustrated and preferred embodiment, the coupled electrode segments 44 transmit radio frequency (RF) electromagnetic energy.
  • RF radio frequency
  • the ablation energy from the coupled electrode segments pass through tissue, typically to an external patch electrode (forming a unipolar arrangement) .
  • the transmitted energy can pass through tissue to a separate adjacent electrode in the heart chamber (forming a bipolar arrangement) .
  • the radio frequency energy heats the tissue, mostly ohmically, forming a lesion.
  • a controller 43 preferably governs the conveyance of radio frequency ablation energy from the generator 42 to the selected coupled electrode segments 44.
  • the array of electrode segments 44 carries one or more temperature sensing elements 104, which are coupled to the controller 43. Temperatures sensed by the temperature sensing elements 104 are processed by the controller 43. Based upon temperature input, the controller 43 adjusts the time and power level of radio frequency energy transmissions by the coupled electrode segments 44, to achieve the desired lesion patterns and other ablation objectives.
  • the temperature sensing elements 104 can take the form of thermistors, thermocouples, or the equivalent.
  • the body 22 can itself be electrically conductive, having a resistivity similar to the tissue it contacts (i.e., about 500 ohm-cm) , or greater or more than this amount.
  • the body can be made conductive by the inclusion by coextrusion of an electrically conductive material, like carbon black or chopped carbon fiber.
  • the electrically conductive body 22 is used in association with an interior electrode 200, like that shown in Fig. 8.
  • a hypertonic saline solution 204 also fills the interior of the electrically conductive body 22 (as also shown in Fig. 8) , to serve as an electrically conductive path to convey radio frequency energy from the electrode 200 to the body 22.
  • the electrically conductive body 22 functions as a "leaky” capacitor in transmitting radio frequency energy from the interior electrode 200 to tissue.
  • the amount of electrically conductive material coextruded into the body 22 affects the electrical conductivity, and thus the electrical resistivity of the body 22, which varies inversely with conductivity. Addition of more electrically conductive material increases electrical conductivity of the body 22, thereby reducing electrical resistivity of the body 22, and vice versa.
  • the user selects a body 22 with a given resistivity according to a function that correlates desired lesion characteristics with the electrical resistivity values of the associated body 22. According to this function, resistivities equal to or greater that about 500 ohm*cm result in more shallow lesions, while resistivities less than about 500 ohm*cm result in deeper lesions, and vice versa.
  • the body 22 can be made electrically conductive by being made porous. Used in association with the interior electrode 200 and hypertonic solution 204 within the body 22, the pores of the porous body 22 establishes ionic transport of ablation energy from the electrode 200, through the electrically conductive medium 204, to tissue outside the body.
  • the electrode segments 44 can be used in tandem with the electrically conductive body to convey radio frequency energy to ablate tissue.
  • the controller 40 electrically couples a grid of adjacent electrode segments 44 together to a source 42 of ablation energy
  • the interior electrode 200 also receives radio frequency energy for transmission by the medium 204 through the electrically conductive body 22.
  • the conductive body 22 extends the effective surface area of the coupled segments 44, thereby enhancing the ablation effect. If the body 22 is porous enough to actually perfuse liquid, an interior electrode 200 is not required to increase the effective electrode surface area of the segments 44. The perfusion of hypertonic liquid through the pores at the time the regions transmit radio frequency energy is itself sufficient to increase the effective transmission surface area of the segments 44.
  • the segments 44 can themselves be made from a porous, electrically conducting material. In this way, ionic transport can occur by mass transfer or perfusion through the segment 44 themselves.
  • the expandable-collapsible electrode structure 20 shown in Fig. 2 can also be used in association with conventional pacing apparatus (not shown) for pacing the heart to acquire electrograms in a conventional fashion.
  • the pacing apparatus is electrically coupled to the connectors 38 to provide a pacing signal to a selected one electrode segment 44, generating depolarization foci at selected sites within the heart.
  • the electrode segments 44 also serve to sense the resulting electrical events for the creation of electrograms. Used in this fashion, the structure 20 can accommodate both pace mapping and entrainment pacing techniques.
  • the expanded structure 20 can also be used to convey pacing signals to confirm contact between tissue and the segments 44. The ability to carry out pacing to sense tissue contact is unexpected, given that the expanded structure 20 presents a surface area significantly greater than that presented by a conventional 4mm/8F electrode.
  • Fig. 9 shows an expandable- collapsible body 22, as previously described, which carries an electrically conductive shell 300 that has been segmented into separate electrode zones 302 arranged in a concentric "bulls eye" pattern about the distal tip of the body 22.
  • the shell 300 can be segmented into axially elongated, circumferentially spaced electrode zones 302.
  • the electrode zones 302 are formed by masking regions on the body 22 which are to be free of the shell 300.
  • a metal material having a relatively high electrical conductivity, as well as a relative high thermal conductivity, such as gold, platinum, platinum/iridium, among others, is deposited upon the unmasked regions on the body 22 by sputtering, vapor deposition, ion beam deposition, electroplating over a deposited seed layer, or a combination of these processes.
  • preformed foil shells can be applied in axially spaced bands on the distal region to form the segmented zones.
  • the segmented zones can comprise signal wire snaked through the wall with noninsulated signal wire portions exposed on the exterior wall.
  • each zone 302 is coupled to a dedicated signal wire or a dedicated set of signal wires (not shown) .
  • the controller 43 can direct ablation energy differently to each zone according to prescribed criteria.
  • a pacing signal can be conveyed to a selected one electrode zone.
  • the electrode zones 302 can also serve to sense the resulting electrical events for the creation of electrograms.
  • bipolar electrode segments 304 are placed in the regions between the zones 304.
  • These bipolar electrode segments 304 like the zones 302 themselves, comprise metal materials, such as gold, platinum, platinum/iridium, among others, deposited upon the body 22 by sputtering, vapor deposition, ion beam deposition, electroplating over a deposited seed layer, or a combination of these processes.
  • preformed foil patches can be applied to form the bipolar segments.
  • the bipolar segments 304 are electrically coupled to signal wires (not shown) to allow bipolar electrogram acquisition, pacing, or E-Characteristic measurements.
  • signal wires not shown
  • the interior surface of the body 22 can also carry electrodes 306 suitable for unipolar or bipolar sensing or pacing or sensing of E-Characteristics.
  • Different electrode placements can be used for unipolar or bipolar sensing or pacing.
  • pairs of 2-mm length and 1-mm width electrodes 306 can be deposited on the interior surface of the body 22.
  • Connection wires (not shown) can be attached to these electrodes 306.
  • the interelectrode distance is about 1 mm to insure good quality bipolar electrograms.
  • Preferred placements of these interior electrodes 306 are at the distal tip and center of the structure 22. Also, when multiple zones 302 are used, it is desired to have the electrodes 306 placed in between the zones 302.
  • Fig. 10 it is preferred to deposit opaque markers 308 on the interior surface of the body 22 so that the physician can guide the device under fluoroscopy to the targeted site.
  • Any high-atomic weight material is suitable for this purpose.
  • platinum, platinum-iridium. can be used to build the markers 106. Preferred placements of these markers 308 are at the distal tip and center of the structure 22.
  • Fig. 11 shows a structure 310 for mapping electrical activity within the heart without physical contact between the structure and endocardial tissue.
  • the structure 310 comprises an expandable-collapsible body that takes the form of a mesh 312 made from interwoven resilient, inert wire or plastic filaments preformed to the desired expanded geometry.
  • a sliding sheath (as previously shown and described in conjunction with Fig. 6) advanced along the catheter tube 12 compresses the mesh structure 312 to collapse it. Likewise, retraction of the sheath removes the compression force, and the freed mesh structure 312 springs open.
  • the mesh structure 312 serves as the support for the electrode segments 44, which can be deposited on the filaments as on a shell supported by the filaments.
  • all or a portion of the mesh filaments could be made electrically conductive.
  • the network of the filaments makes it possible to form electrodes whose spacial location can be determined.
  • the mesh structure 312 can be made to normally assume the collapsed geometry.
  • one or more interior bladders 314 can accommodate the introduction of an inflation medium to cause the mesh structure 312 to assume the expanded geometry.
  • the interior bladder could be eliminated.
  • a biocompatible liquid such as sterile saline
  • the expandable-collapsible mesh structure 312 can be positioned within the blood pool of a heart chamber.
  • the electrode segments 44 sense electrical potentials in blood. Electrical potentials in myocardial tissue can be inferred from the sensed blood potentials, without actual contact with the endocardium. Further details of this methodology are found in Pilkington, Loftis, Thompson et al.(Ed.), High Performance Computing in Biomedical Research (Part 3) , "Inverse Problems and Computational Methods," CRC Press, Inc.

Abstract

L'invention porte sur des systèmes et procédés de chauffage de tissus corporels à structure multifonctionnelle (22) dont la paroi extérieure est en contact avec lesdits tissus. Ladite structure comporte un réseau de segments d'électrodes électroconducteurs (44) porté par la paroi extérieure. Un réseau électroconducteur est raccordé aux segments d'électrode par au moins une liaison électroconductrice (32) reliant individuellement chaque segment d'électrode. Les systèmes et les procédés peuvent fonctionner dans un premier mode où le système est réglé pour détecter séparément sur chaque segment d'électrode des événements électriques locaux tels que des potentiels électriques, la résistivité ou l'impédance, et dans un second mode où le réseau électrique est réglé, en partie en fonctions des événements détectés par les segments d'électrodes, pour relier au moins deux d'entre eux en vue de la transmission simultanée d'énergie électrique pour le chauffage ou l'ablation d'une zone de tissus corporels.
PCT/US1997/000896 1996-01-19 1997-01-17 Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels WO1997025917A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP9526268A JP2000504242A (ja) 1996-01-19 1997-01-17 体の組織を電気的に分析し加熱するための多機能電極構造体
EP97903022A EP0879015A4 (fr) 1996-01-19 1997-01-17 Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US1035496P 1996-01-19 1996-01-19
US1022396P 1996-01-19 1996-01-19
US1022596P 1996-01-19 1996-01-19
US60/010,225 1996-01-19
US60/010,354 1996-01-19
US60/010,223 1996-01-19
US08/629,014 US5836874A (en) 1996-04-08 1996-04-08 Multi-function electrode structures for electrically analyzing and heating body tissue
US08/629,014 1996-04-08

Publications (2)

Publication Number Publication Date
WO1997025917A1 true WO1997025917A1 (fr) 1997-07-24
WO1997025917A9 WO1997025917A9 (fr) 1997-10-09

Family

ID=27485982

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/000896 WO1997025917A1 (fr) 1996-01-19 1997-01-17 Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels

Country Status (4)

Country Link
EP (1) EP0879015A4 (fr)
JP (1) JP2000504242A (fr)
CA (1) CA2243595A1 (fr)
WO (1) WO1997025917A1 (fr)

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6400981B1 (en) 2000-06-21 2002-06-04 Biosense, Inc. Rapid mapping of electrical activity in the heart
JP2003510126A (ja) * 1999-09-28 2003-03-18 ノヴァシス メディカル インコーポレイテッド エネルギーと薬の適用による組織の処置
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
WO2005089663A1 (fr) * 2004-03-05 2005-09-29 Medelec-Minimeca S.A. Catheter amelioree par une solution saline pour l'ablation tumorale par radiofrequence
WO2005112812A1 (fr) * 2004-05-14 2005-12-01 Medtronic, Inc. Méthode et dispositifs pour le traitement de fibrillation auriculaire par ablation de masse
US7850685B2 (en) 2005-06-20 2010-12-14 Medtronic Ablation Frontiers Llc Ablation catheter
WO2011060200A1 (fr) * 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Systèmes, appareils et procédés pour traiter un tissu et contrôler une sténose
US8273084B2 (en) 2004-11-24 2012-09-25 Medtronic Ablation Frontiers Llc Atrial ablation catheter and method of use
US8486063B2 (en) 2004-10-14 2013-07-16 Medtronic Ablation Frontiers Llc Ablation catheter
US8617152B2 (en) 2004-11-15 2013-12-31 Medtronic Ablation Frontiers Llc Ablation system with feedback
US8641704B2 (en) 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
WO2014047068A1 (fr) * 2012-09-18 2014-03-27 Boston Scientific Scimed, Inc. Cartographie et retrait de cathéter d'ablation refroidi à boucle fermée
EP2724683A1 (fr) * 2012-10-26 2014-04-30 Biosense Webster (Israel), Ltd. Cathéter d'ablation irrigué avec tête déformable
WO2014164847A1 (fr) * 2013-03-12 2014-10-09 Boston Scientific Scimed, Inc. Dispositif d'extraction et procédés d'utilisation associés
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9005194B2 (en) 2004-11-24 2015-04-14 Medtronic Ablation Frontiers Llc Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US9211156B2 (en) 2012-09-18 2015-12-15 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter with flat tip
WO2015187430A3 (fr) * 2014-06-04 2016-04-21 Boston Scientific Scimed, Inc. Ensemble électrode
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US9393072B2 (en) 2009-06-30 2016-07-19 Boston Scientific Scimed, Inc. Map and ablate open irrigated hybrid catheter
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9463064B2 (en) 2011-09-14 2016-10-11 Boston Scientific Scimed Inc. Ablation device with multiple ablation modes
US9474467B2 (en) 2008-04-02 2016-10-25 Rhythmia Medical, Inc. Intracardiac tracking system
US9585588B2 (en) 2014-06-03 2017-03-07 Boston Scientific Scimed, Inc. Electrode assembly having an atraumatic distal tip
US9603659B2 (en) 2011-09-14 2017-03-28 Boston Scientific Scimed Inc. Ablation device with ionically conductive balloon
WO2017087740A1 (fr) * 2015-11-20 2017-05-26 St. Jude Medical, Cardiology Division, Inc. Pointe d'instrument d'ablation multi-électrode ayant des capacités de retour omnidirectionnel bimode
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US9743854B2 (en) 2014-12-18 2017-08-29 Boston Scientific Scimed, Inc. Real-time morphology analysis for lesion assessment
US9757193B2 (en) 2002-04-08 2017-09-12 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatus for renal neuromodulation
US9757191B2 (en) 2012-01-10 2017-09-12 Boston Scientific Scimed, Inc. Electrophysiology system and methods
US9827040B2 (en) 2002-04-08 2017-11-28 Medtronic Adrian Luxembourg S.a.r.l. Methods and apparatus for intravascularly-induced neuromodulation
US9919144B2 (en) 2011-04-08 2018-03-20 Medtronic Adrian Luxembourg S.a.r.l. Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
CN108156804A (zh) * 2015-05-21 2018-06-12 蛇牌股份公司 电外科凝固器械
US10034637B2 (en) 2007-12-28 2018-07-31 Boston Scientific Scimed, Inc. Cardiac mapping catheter
EP3495018A1 (fr) * 2014-05-07 2019-06-12 Farapulse, Inc. Appareil d'ablation de tissus sélectifs
US10420605B2 (en) 2012-01-31 2019-09-24 Koninklijke Philips N.V. Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging
US10433908B2 (en) 2016-01-05 2019-10-08 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10512779B2 (en) 2016-01-05 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US10524684B2 (en) 2014-10-13 2020-01-07 Boston Scientific Scimed Inc Tissue diagnosis and treatment using mini-electrodes
US10603105B2 (en) 2014-10-24 2020-03-31 Boston Scientific Scimed Inc Medical devices with a flexible electrode assembly coupled to an ablation tip
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10617467B2 (en) 2017-07-06 2020-04-14 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10631928B2 (en) 2017-03-24 2020-04-28 Biosense Webster (Israel) Ltd. Catheter with deformable distal electrode
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US10758144B2 (en) 2015-08-20 2020-09-01 Boston Scientific Scimed Inc. Flexible electrode for cardiac sensing and method for making
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US11058879B2 (en) 2008-02-15 2021-07-13 Nuvaira, Inc. System and method for bronchial dilation
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US20210346694A1 (en) * 2016-08-18 2021-11-11 Novocure Gmbh Temperature Measurement in Arrays for Delivering TTFields
US11241282B2 (en) 2014-06-12 2022-02-08 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US11426573B2 (en) 2012-08-09 2022-08-30 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region
US11439298B2 (en) 2013-04-08 2022-09-13 Boston Scientific Scimed, Inc. Surface mapping and visualizing ablation system
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11684416B2 (en) 2009-02-11 2023-06-27 Boston Scientific Scimed, Inc. Insulated ablation catheter devices and methods of use

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6496712B1 (en) * 2000-05-01 2002-12-17 Biosense Webster, Inc. Method and apparatus for electrophysiology catheter with enhanced sensing
US20050059963A1 (en) * 2003-09-12 2005-03-17 Scimed Life Systems, Inc. Systems and method for creating transmural lesions
US7438714B2 (en) * 2003-09-12 2008-10-21 Boston Scientific Scimed, Inc. Vacuum-based catheter stabilizer
WO2007008954A2 (fr) 2005-07-11 2007-01-18 Ablation Frontiers Systeme d'ablation de tissu a faible consommation d'energie
WO2010020958A1 (fr) * 2008-08-22 2010-02-25 Koninklijke Philips Electronics N.V. Appareil de détection destiné à détecter un objet
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
EP2370015B1 (fr) * 2008-11-11 2016-12-21 Shifamed Holdings, LLC Ensemble d'électrodes à faible profil
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
WO2011143468A2 (fr) 2010-05-12 2011-11-17 Shifamed, Llc Assemblage d'électrode à faible profil
US9687196B2 (en) * 2011-04-07 2017-06-27 Sanovas, Inc. Electrically conductive balloon catheter
CN105228547B (zh) 2013-04-08 2019-05-14 阿帕玛医疗公司 心脏消融导管
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
AU2015350007A1 (en) * 2014-11-19 2017-06-29 Epix Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
WO2016081611A1 (fr) * 2014-11-19 2016-05-26 Advanced Cardiac Therapeutics, Inc. Cartographie haute résolution de tissus avec stimulation cardiaque
EP3376936B1 (fr) 2015-11-16 2024-01-03 Boston Scientific Scimed, Inc. Dispositifs délivrant de l'énergie
US10653480B2 (en) * 2016-04-28 2020-05-19 Biosense Webster (Israel) Ltd. Method for constructing irrigated balloon catheter with flexible circuit electrode assembly
US11957852B2 (en) 2021-01-14 2024-04-16 Biosense Webster (Israel) Ltd. Intravascular balloon with slidable central irrigation tube

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334193A (en) * 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5462545A (en) * 1994-01-31 1995-10-31 New England Medical Center Hospitals, Inc. Catheter electrodes
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5598848A (en) * 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5263493A (en) * 1992-02-24 1993-11-23 Boaz Avitall Deflectable loop electrode array mapping and ablation catheter for cardiac chambers

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334193A (en) * 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5462545A (en) * 1994-01-31 1995-10-31 New England Medical Center Hospitals, Inc. Catheter electrodes
US5598848A (en) * 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0879015A4 *

Cited By (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003510126A (ja) * 1999-09-28 2003-03-18 ノヴァシス メディカル インコーポレイテッド エネルギーと薬の適用による組織の処置
US6892091B1 (en) 2000-02-18 2005-05-10 Biosense, Inc. Catheter, method and apparatus for generating an electrical map of a chamber of the heart
US6400981B1 (en) 2000-06-21 2002-06-04 Biosense, Inc. Rapid mapping of electrical activity in the heart
US9827040B2 (en) 2002-04-08 2017-11-28 Medtronic Adrian Luxembourg S.a.r.l. Methods and apparatus for intravascularly-induced neuromodulation
US9827041B2 (en) 2002-04-08 2017-11-28 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatuses for renal denervation
US9757193B2 (en) 2002-04-08 2017-09-12 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatus for renal neuromodulation
US10105180B2 (en) 2002-04-08 2018-10-23 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
US10376311B2 (en) 2002-04-08 2019-08-13 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
US10420606B2 (en) 2002-04-08 2019-09-24 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US10953170B2 (en) 2003-05-13 2021-03-23 Nuvaira, Inc. Apparatus for treating asthma using neurotoxin
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US7771420B2 (en) 2004-03-05 2010-08-10 Medelec-Minimeca S.A. Saline-enhanced catheter for radiofrequency tumor ablation
WO2005089663A1 (fr) * 2004-03-05 2005-09-29 Medelec-Minimeca S.A. Catheter amelioree par une solution saline pour l'ablation tumorale par radiofrequence
WO2005112812A1 (fr) * 2004-05-14 2005-12-01 Medtronic, Inc. Méthode et dispositifs pour le traitement de fibrillation auriculaire par ablation de masse
US8486063B2 (en) 2004-10-14 2013-07-16 Medtronic Ablation Frontiers Llc Ablation catheter
US9642675B2 (en) 2004-10-14 2017-05-09 Medtronic Ablation Frontiers Llc Ablation catheter
US8617152B2 (en) 2004-11-15 2013-12-31 Medtronic Ablation Frontiers Llc Ablation system with feedback
US9005194B2 (en) 2004-11-24 2015-04-14 Medtronic Ablation Frontiers Llc Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use
US8273084B2 (en) 2004-11-24 2012-09-25 Medtronic Ablation Frontiers Llc Atrial ablation catheter and method of use
US8337492B2 (en) 2005-06-20 2012-12-25 Medtronic Ablation Frontiers Llc Ablation catheter
US8771267B2 (en) 2005-06-20 2014-07-08 Medtronic Ablation Frontiers Llc Ablation catheter
US9468495B2 (en) 2005-06-20 2016-10-18 Medtronic Ablation Frontiers Llc Ablation catheter
US8979841B2 (en) 2005-06-20 2015-03-17 Medtronic Ablation Frontiers Llc Ablation catheter
US7850685B2 (en) 2005-06-20 2010-12-14 Medtronic Ablation Frontiers Llc Ablation catheter
US8657814B2 (en) 2005-08-22 2014-02-25 Medtronic Ablation Frontiers Llc User interface for tissue ablation system
US8771269B2 (en) 2007-05-11 2014-07-08 Medtronic Ablation Frontiers Llc RF energy delivery system and method
US10219857B2 (en) 2007-05-11 2019-03-05 Medtronic Ablation Frontiers Llc RF energy delivery system
US8641704B2 (en) 2007-05-11 2014-02-04 Medtronic Ablation Frontiers Llc Ablation therapy system and method for treating continuous atrial fibrillation
US10034637B2 (en) 2007-12-28 2018-07-31 Boston Scientific Scimed, Inc. Cardiac mapping catheter
US11272886B2 (en) 2007-12-28 2022-03-15 Boston Scientific Scimed, Inc. Cardiac mapping catheter
US11058879B2 (en) 2008-02-15 2021-07-13 Nuvaira, Inc. System and method for bronchial dilation
US9474467B2 (en) 2008-04-02 2016-10-25 Rhythmia Medical, Inc. Intracardiac tracking system
US10149714B2 (en) 2008-05-09 2018-12-11 Nuvaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US11937868B2 (en) 2008-05-09 2024-03-26 Nuvaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US11684416B2 (en) 2009-02-11 2023-06-27 Boston Scientific Scimed, Inc. Insulated ablation catheter devices and methods of use
US9393072B2 (en) 2009-06-30 2016-07-19 Boston Scientific Scimed, Inc. Map and ablate open irrigated hybrid catheter
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US10610283B2 (en) 2009-11-11 2020-04-07 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US10363091B2 (en) 2009-11-11 2019-07-30 Nuvaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
WO2011060200A1 (fr) * 2009-11-11 2011-05-19 Innovative Pulmonary Solutions, Inc. Systèmes, appareils et procédés pour traiter un tissu et contrôler une sténose
CN102711645A (zh) * 2009-11-11 2012-10-03 创新肺部方案公司 用于处理组织和控制狭窄的系统、装置和方法
US11712283B2 (en) 2009-11-11 2023-08-01 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US11389233B2 (en) 2009-11-11 2022-07-19 Nuvaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9919144B2 (en) 2011-04-08 2018-03-20 Medtronic Adrian Luxembourg S.a.r.l. Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US9463064B2 (en) 2011-09-14 2016-10-11 Boston Scientific Scimed Inc. Ablation device with multiple ablation modes
US9603659B2 (en) 2011-09-14 2017-03-28 Boston Scientific Scimed Inc. Ablation device with ionically conductive balloon
US9757191B2 (en) 2012-01-10 2017-09-12 Boston Scientific Scimed, Inc. Electrophysiology system and methods
US10420605B2 (en) 2012-01-31 2019-09-24 Koninklijke Philips N.V. Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging
US11426573B2 (en) 2012-08-09 2022-08-30 University Of Iowa Research Foundation Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region
CN104640513A (zh) * 2012-09-18 2015-05-20 波士顿科学医学有限公司 映射以及消融闭环冷却的消融导管
WO2014047068A1 (fr) * 2012-09-18 2014-03-27 Boston Scientific Scimed, Inc. Cartographie et retrait de cathéter d'ablation refroidi à boucle fermée
US9370329B2 (en) 2012-09-18 2016-06-21 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter
US9211156B2 (en) 2012-09-18 2015-12-15 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter with flat tip
CN109009420A (zh) * 2012-10-26 2018-12-18 韦伯斯特生物官能(以色列)有限公司 具有可变形头部的冲洗式消融导管
EP3494915A1 (fr) * 2012-10-26 2019-06-12 Biosense Webster (Israel) Ltd. Cathéter d'ablation irrigué avec tête déformable
EP2724683A1 (fr) * 2012-10-26 2014-04-30 Biosense Webster (Israel), Ltd. Cathéter d'ablation irrigué avec tête déformable
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9855066B2 (en) 2013-03-12 2018-01-02 Boston Scientific Scimed, Inc. Retrieval device and related methods of use
WO2014164847A1 (fr) * 2013-03-12 2014-10-09 Boston Scientific Scimed, Inc. Dispositif d'extraction et procédés d'utilisation associés
US11439298B2 (en) 2013-04-08 2022-09-13 Boston Scientific Scimed, Inc. Surface mapping and visualizing ablation system
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US10517672B2 (en) 2014-01-06 2019-12-31 Farapulse, Inc. Apparatus and methods for renal denervation ablation
US11589919B2 (en) 2014-01-06 2023-02-28 Boston Scientific Scimed, Inc. Apparatus and methods for renal denervation ablation
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US11259869B2 (en) 2014-05-07 2022-03-01 Farapulse, Inc. Methods and apparatus for selective tissue ablation
EP3495018A1 (fr) * 2014-05-07 2019-06-12 Farapulse, Inc. Appareil d'ablation de tissus sélectifs
US9585588B2 (en) 2014-06-03 2017-03-07 Boston Scientific Scimed, Inc. Electrode assembly having an atraumatic distal tip
WO2015187430A3 (fr) * 2014-06-04 2016-04-21 Boston Scientific Scimed, Inc. Ensemble électrode
US9848795B2 (en) 2014-06-04 2017-12-26 Boston Scientific Scimed Inc. Electrode assembly
US11622803B2 (en) 2014-06-12 2023-04-11 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US10624693B2 (en) 2014-06-12 2020-04-21 Farapulse, Inc. Method and apparatus for rapid and selective tissue ablation with cooling
US11241282B2 (en) 2014-06-12 2022-02-08 Boston Scientific Scimed, Inc. Method and apparatus for rapid and selective transurethral tissue ablation
US10524684B2 (en) 2014-10-13 2020-01-07 Boston Scientific Scimed Inc Tissue diagnosis and treatment using mini-electrodes
US11589768B2 (en) 2014-10-13 2023-02-28 Boston Scientific Scimed Inc. Tissue diagnosis and treatment using mini-electrodes
US10603105B2 (en) 2014-10-24 2020-03-31 Boston Scientific Scimed Inc Medical devices with a flexible electrode assembly coupled to an ablation tip
US9743854B2 (en) 2014-12-18 2017-08-29 Boston Scientific Scimed, Inc. Real-time morphology analysis for lesion assessment
CN108156804B (zh) * 2015-05-21 2021-07-16 蛇牌股份公司 电外科凝固器械
CN108156804A (zh) * 2015-05-21 2018-06-12 蛇牌股份公司 电外科凝固器械
US10758144B2 (en) 2015-08-20 2020-09-01 Boston Scientific Scimed Inc. Flexible electrode for cardiac sensing and method for making
US10980598B2 (en) 2015-11-20 2021-04-20 St. Jude Medical, Cardiology Division, Inc. Multi-electrode ablator tip having dual-mode, omni-directional feedback capabilities
WO2017087740A1 (fr) * 2015-11-20 2017-05-26 St. Jude Medical, Cardiology Division, Inc. Pointe d'instrument d'ablation multi-électrode ayant des capacités de retour omnidirectionnel bimode
US10660702B2 (en) 2016-01-05 2020-05-26 Farapulse, Inc. Systems, devices, and methods for focal ablation
US11589921B2 (en) 2016-01-05 2023-02-28 Boston Scientific Scimed, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10709891B2 (en) 2016-01-05 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11020179B2 (en) 2016-01-05 2021-06-01 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10512779B2 (en) 2016-01-05 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10433908B2 (en) 2016-01-05 2019-10-08 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10842561B2 (en) 2016-01-05 2020-11-24 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10507302B2 (en) 2016-06-16 2019-12-17 Farapulse, Inc. Systems, apparatuses, and methods for guide wire delivery
US20210346694A1 (en) * 2016-08-18 2021-11-11 Novocure Gmbh Temperature Measurement in Arrays for Delivering TTFields
US10631928B2 (en) 2017-03-24 2020-04-28 Biosense Webster (Israel) Ltd. Catheter with deformable distal electrode
US11766292B2 (en) 2017-03-24 2023-09-26 Biosense Webster (Israel) Ltd. Catheter with deformable distal electrode
US11833350B2 (en) 2017-04-28 2023-12-05 Boston Scientific Scimed, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10617867B2 (en) 2017-04-28 2020-04-14 Farapulse, Inc. Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue
US10617467B2 (en) 2017-07-06 2020-04-14 Farapulse, Inc. Systems, devices, and methods for focal ablation
US10893905B2 (en) 2017-09-12 2021-01-19 Farapulse, Inc. Systems, apparatuses, and methods for ventricular focal ablation
US11020180B2 (en) 2018-05-07 2021-06-01 Farapulse, Inc. Epicardial ablation catheter
US10512505B2 (en) 2018-05-07 2019-12-24 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US11033236B2 (en) 2018-05-07 2021-06-15 Farapulse, Inc. Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation
US10709502B2 (en) 2018-05-07 2020-07-14 Farapulse, Inc. Systems, apparatuses and methods for delivery of ablative energy to tissue
US10687892B2 (en) 2018-09-20 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue
US10625080B1 (en) 2019-09-17 2020-04-21 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US10688305B1 (en) 2019-09-17 2020-06-23 Farapulse, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US11738200B2 (en) 2019-09-17 2023-08-29 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation
US11497541B2 (en) 2019-11-20 2022-11-15 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11065047B2 (en) 2019-11-20 2021-07-20 Farapulse, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11684408B2 (en) 2019-11-20 2023-06-27 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US11931090B2 (en) 2019-11-20 2024-03-19 Boston Scientific Scimed, Inc. Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses
US10842572B1 (en) 2019-11-25 2020-11-24 Farapulse, Inc. Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines

Also Published As

Publication number Publication date
CA2243595A1 (fr) 1997-07-24
EP0879015A4 (fr) 1999-11-17
EP0879015A1 (fr) 1998-11-25
JP2000504242A (ja) 2000-04-11

Similar Documents

Publication Publication Date Title
US5836874A (en) Multi-function electrode structures for electrically analyzing and heating body tissue
WO1997025917A1 (fr) Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels
WO1997025917A9 (fr) Structures multifonctionnelles d'electrodes destinees a l'analyse et au chauffage electriques de tissus corporels
US5830213A (en) Systems for heating and ablating tissue using multifunctional electrode structures
US5840076A (en) Tissue heating and ablation systems and methods using electrode structures with distally oriented porous regions
US5961513A (en) Tissue heating and ablation systems and methods using porous electrode structures
EP1663044B1 (fr) Dispositif de sonde pour la formation de lesions circonferentielles au sein d'un ostium
US6475213B1 (en) Method of ablating body tissue
US5868736A (en) Systems and methods to control tissue heating or ablation with porous electrode structures
US5846239A (en) Tissue heating and ablation systems and methods using segmented porous electrode structures
US5797903A (en) Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces
US7569052B2 (en) Ablation catheter with tissue protecting assembly
US6071278A (en) Tissue heating and ablation systems and methods using porous electrode structures with specified electrical resistivities
US5879348A (en) Electrode structures formed from flexible, porous, or woven materials
US7438714B2 (en) Vacuum-based catheter stabilizer
US6099526A (en) Electrode structure including hydrophilic material
US6620159B2 (en) Conductive expandable electrode body and method of manufacturing the same
US6290697B1 (en) Self-guiding catheter system for tissue ablation
US11553961B2 (en) Catheter with stretchable irrigation tube
US20050059963A1 (en) Systems and method for creating transmural lesions
US20050059862A1 (en) Cannula with integrated imaging and optical capability
WO1997025918A9 (fr) Structures d'electrodes formees a partir de materiaux flexibles, poreux ou tisses
WO1997045156A9 (fr) Systemes et procedes de chauffage et d'ablation des tissus utilisant des structures d'electrodes poreuses
WO1997045156A2 (fr) Systemes et procedes de chauffage et d'ablation des tissus utilisant des structures d'electrodes poreuses
US20010044625A1 (en) Catheter for circular tissue ablation and methods thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1/5/5/5,DRAWINGS,REPLACED BY NEW PAGES 1/7-7/7;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1997903022

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2243595

Country of ref document: CA

Ref country code: CA

Ref document number: 2243595

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1997903022

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997903022

Country of ref document: EP